GLSV news
01.02.2013 Global Life Science Ventures: 2012 Review 
more...
30.01.2012 Global Life Science Ventures: 2011 Review
more...
24.01.2011 Global Life Science Ventures: 2010 Review
more...
14.01.2010 Global Life Science Ventures: 2009 Review
more...
13.02.2009 Global Life Science Ventures: 2008 highlights
more...
22.04.2008 GLSV receives 2007 Dyodelta European Life Science Innovation Award "Investor of the Year Award"
more...
14.04.2008 April 2008 Teil 20 der Serie: Köpfe der deutschsprachigen Private Equity-Szene, Hanns-Peter Wiese, Venture Capial Magazin 4/2008
more...
17.01.2008 GLSV leads investment in Action Pharma A/S
more...
06.12.2007 GLSV invests in Pelikan Technologies
more...
02.10.2007 Biotech Investment Barometer Reveals Continued Confidence in Sector
more...
............................................................................................
Portfolio company news
18.04.2013 Pieris Achieves Second Milestone Payment in Daiichi Sankyo Collaboration to Develop Anticalin® Therapeutics
more...
16.04.2013 Santaris Pharma announces a worldwide discovery alliance with Bristol-Myers Squibb for RNA-targeted medicines
more...
10.04.2013 Pieris and Sanofi Broaden Existing Collaboration
more...
27.03.2013 Research Published in the New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S’ Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials
more...
11.02.2013 Horizon Pharma Announces Preliminary Fourth Quarter and Full Year 2012 Revenues, Full U.S. Commercial Launch of RAYOS(R) (Prednisone) Delayed-Release Tablets and Approval of LODOTRA(R) in South Korea
more...
08.01.2013 Santaris Pharma A/S and miRagen Therapeutics Inc. expand worldwide strategic alliance to discover and develop LNA-drugs against disease causing microRNAs
more...
07.01.2013 USPTO Grants Santaris' Request for Inter-Partes Reexamination of Patent licensed to Regulus
more...
03.12.2012 Horizon Pharma Begins Initial Commercial Launch of RAYOS(R) (prednisone) Delayed-Release Tablets in the United States
more...
29.11.2012 Pieris Presents Data and Reveals Targets for Anticalin Bispecific PRS-190 at European Antibody Congress
more...
22.11.2012 Agendia announces discovery of a gene signature that predicts response to a broad range of cancer drugs
more...
